134 related articles for article (PubMed ID: 38331308)
21. Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions.
El Kholy K; Freire M; Chen T; Van Dyke TE
Front Immunol; 2018; 9():1300. PubMed ID: 29946319
[TBL] [Abstract][Full Text] [Related]
22. A Signature of Circulating miRNAs Associated With Fibrous Dysplasia of Bone: the mirDys Study.
Legrand MA; Millet M; Merle B; Rousseau JC; Hemmendinger A; Gineyts E; Sornay-Rendu E; Szulc P; Borel O; Croset M; Chapurlat R
J Bone Miner Res; 2020 Oct; 35(10):1881-1892. PubMed ID: 32526052
[TBL] [Abstract][Full Text] [Related]
23. Osteomalacic and hyperparathyroid changes in fibrous dysplasia of bone: core biopsy studies and clinical correlations.
Corsi A; Collins MT; Riminucci M; Howell PG; Boyde A; Robey PG; Bianco P
J Bone Miner Res; 2003 Jul; 18(7):1235-46. PubMed ID: 12854833
[TBL] [Abstract][Full Text] [Related]
24. Potent constitutive cyclic AMP-generating activity of XLαs implicates this imprinted GNAS product in the pathogenesis of McCune-Albright syndrome and fibrous dysplasia of bone.
Mariot V; Wu JY; Aydin C; Mantovani G; Mahon MJ; Linglart A; Bastepe M
Bone; 2011 Feb; 48(2):312-20. PubMed ID: 20887824
[TBL] [Abstract][Full Text] [Related]
25. Bisphosphonates for the treatment of fibrous dysplasia of bone.
Chapurlat R; Legrand MA
Bone; 2021 Feb; 143():115784. PubMed ID: 33276154
[TBL] [Abstract][Full Text] [Related]
26. GNAS transcripts in skeletal progenitors: evidence for random asymmetric allelic expression of Gs alpha.
Michienzi S; Cherman N; Holmbeck K; Funari A; Collins MT; Bianco P; Robey PG; Riminucci M
Hum Mol Genet; 2007 Aug; 16(16):1921-30. PubMed ID: 17566083
[TBL] [Abstract][Full Text] [Related]
27. Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.
Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Sasaki T; Hatano H; Hotta T; Endo N
PLoS One; 2016; 11(5):e0154680. PubMed ID: 27163152
[TBL] [Abstract][Full Text] [Related]
28. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone.
Bianco P; Riminucci M; Majolagbe A; Kuznetsov SA; Collins MT; Mankani MH; Corsi A; Bone HG; Wientroub S; Spiegel AM; Fisher LW; Robey PG
J Bone Miner Res; 2000 Jan; 15(1):120-8. PubMed ID: 10646121
[TBL] [Abstract][Full Text] [Related]
29. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
30. Denosumab treatment for fibrous dysplasia.
Boyce AM; Chong WH; Yao J; Gafni RI; Kelly MH; Chamberlain CE; Bassim C; Cherman N; Ellsworth M; Kasa-Vubu JZ; Farley FA; Molinolo AA; Bhattacharyya N; Collins MT
J Bone Miner Res; 2012 Jul; 27(7):1462-70. PubMed ID: 22431375
[TBL] [Abstract][Full Text] [Related]
31. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
32. Clinical value of RANKL, OPG, IL-6 and sclerostin as biomarkers for fibrous dysplasia/McCune-Albright syndrome.
Meier ME; Hagelstein-Rotman M; Streefland TCM; Winter EM; Bravenboer N; Appelman-Dijkstra NM
Bone; 2023 Jun; 171():116744. PubMed ID: 36958543
[TBL] [Abstract][Full Text] [Related]
33. Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome.
Yamamoto T; Ozono K; Kasayama S; Yoh K; Hiroshima K; Takagi M; Matsumoto S; Michigami T; Yamaoka K; Kishimoto T; Okada S
J Clin Invest; 1996 Jul; 98(1):30-5. PubMed ID: 8690800
[TBL] [Abstract][Full Text] [Related]
34. Induced
Khan SK; Yadav PS; Elliott G; Hu DZ; Xu R; Yang Y
Proc Natl Acad Sci U S A; 2018 Jan; 115(3):E418-E427. PubMed ID: 29158412
[TBL] [Abstract][Full Text] [Related]
35. Advances in Models of Fibrous Dysplasia/McCune-Albright Syndrome.
Lung H; Hsiao EC; Wentworth KL
Front Endocrinol (Lausanne); 2019; 10():925. PubMed ID: 32038487
[TBL] [Abstract][Full Text] [Related]
36. Overloaded Orthopedic Force Induces Condylar Subchondral Bone Absorption by Stimulating Rat Mesenchymal Stem Cells Differentiating into Osteoclasts via mTOR-Regulated
Tian Y; Chen J; Yan X; Ren D; Liu M; Zhang Q; Zhang Q; Yuan X
Stem Cells Dev; 2021 Jan; 30(1):29-38. PubMed ID: 33176606
[TBL] [Abstract][Full Text] [Related]
37. Celecoxib treatment of fibrous dysplasia (FD) in a human FD cell line and FD-like lesions in mice with protein kinase A (PKA) defects.
Saloustros E; Liu S; Mertz EL; Bhattacharyya N; Starost MF; Salpea P; Nesterova M; Collins M; Leikin S; Stratakis CA
Mol Cell Endocrinol; 2017 Jan; 439():165-174. PubMed ID: 27498419
[TBL] [Abstract][Full Text] [Related]
38. Gene expression patterns in the bone tissue of women with fibrous dysplasia.
Kiss J; Balla B; Kósa JP; Borsy A; Podani J; Takács I; Lazáry A; Nagy Z; Bácsi K; Kis A; Szlávy E; Szendroi M; Speer G; Orosz L; Lakatos P
Am J Med Genet A; 2010 Sep; 152A(9):2211-20. PubMed ID: 20683988
[TBL] [Abstract][Full Text] [Related]
39. Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia.
Kobayashi K; Imanishi Y; Koshiyama H; Miyauchi A; Wakasa K; Kawata T; Goto H; Ohashi H; Koyano HM; Mochizuki R; Miki T; Inaba M; Nishizawa Y
Life Sci; 2006 Apr; 78(20):2295-301. PubMed ID: 16337659
[TBL] [Abstract][Full Text] [Related]
40. Osteoclasts: more than 'bone eaters'.
Charles JF; Aliprantis AO
Trends Mol Med; 2014 Aug; 20(8):449-59. PubMed ID: 25008556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
